A Landmark Lawsuit for Gender-Confused Minors

The British High Court bans puberty-blocking drugs for under-16s.

Share this story

A transgender rights activist waves a transgender flag, N.Y., May 24, 2019.

Demetrius Freeman/Reuters

There is perhaps no aspect of the gender-identity debate more emotionally fraught than the question of what to do about children who say they are transgender. In recent years, lavishly funded transgender-lobby groups have fought hard to implement what they claim is a medical “pause button” whereby gender-dysphoric children and young people are administered “puberty-blocking” drugs that, activists claim, buy these minors more time on the road to transition.

Only the most pernicious of euphemisms can justify such a gung-ho approach to this medical intervention. For not only are these drugs experimental, but they are also, in almost every instance, followed by a regimen of cross-sex hormones that compromises a young person’s fertility and sexual function. Puberty blockers are not a “pause button,” then, but a nuclear button, setting children on the path to irreversible bodily impairment they may well deeply regret. (This, of course, is to say nothing of the fact that the vast majority of children grow out of gender dysphoria by late adolescence.)

Madeleine Kearns

About the Author

Madeleine Kearns

Madeleine Kearns is a former staff writer at National Review.

Comments

Advertisement

Advertisement